Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NPS Allelix Corp.

Division of Takeda Pharmaceutical Co. Ltd.
www.npsp.com

Latest From NPS Allelix Corp.

Drugs that Induce Bone Growth

Inspired by the commercializing of Lilly's osteoporosis drug, Forteo, start-ups are developing new classes of anabolic bone-forming agents around known and novel drug targets.
BioPharmaceutical

When the Body Alone Can't Build Bone

Orthobiologics are now on the horizon, driving suppliers to increase R&D spending. The goal is to develop high-margin products that will actively promote bone formation. Has the slow progress to commercialization of the first two products--bone morphogenic proteins developed by the collaborations of Stryker Corp/Creative Biomolecules and Genetics Institute/Sofamor Danek--helped prime the market to accept a new technology? Or has the perception of delay dampened enthusiasm and scared off some of the big orthopedics players?
BioPharmaceutical Medical Device

Approaching Addiction

Recent insights into the basic mechanisms of substance addiction are invigorating a range of research efforts in industry, academia and especially government. But it's clearly a risky business.
BioPharmaceutical Consumer

Approaching Addiction

Recent insights into the basic mechanisms of substance addiction are invigorating a range of research efforts in industry, academia and especially government. But it's clearly a risky business.
BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Allelix Biopharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Takeda Pharmaceutical Co. Ltd.
  • Senior Management
  • Paul Van Damme, VP, Fin. & CFO
    James H Tripp, SVP, Bus. Dev.
  • Contact Info
  • NPS Allelix Corp.
    Phone: (905) 677-0831
    6850 Goreway Dr.
    Mississauga, L4V 1V7
    Canada
UsernamePublicRestriction

Register